SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is surging following a blowout earnings report where significant Azure growth and strong guidance successfully countered recent market anxiety regarding AI infrastructure costs. Community sentiment has shifted dramatically, with investors celebrating the stock's role in stabilizing the broader market while shorts face intense pressure amid a heavy wave of bullish commentary and price target upgrades.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is experiencing extreme volatility and intense short-squeeze speculation as investors debate whether recent steep losses represent a buying opportunity in the AI infrastructure sector. The community is sharply divided between bulls citing massive hyperscaler capex and long-term AI demand, and skeptics emphasizing concerns over debt, margin call-driven liquidations, and broader market uncertainty.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is seeing significant community debate following a series of robust operational updates, including record-breaking ABS issuances and positive shifts in analyst credit outlooks. While retail investors are actively discussing the stock's potential for a valuation re-rating compared to fintech peers, sentiment remains divided between those betting on long-term fundamental execution and others frustrated by persistent price volatility and broader macro headwinds.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is experiencing significant volatility as investors weigh a strong earnings beat and a massive contracted backlog against broader macro headwinds and sector-wide selling pressure. While the community is actively debating whether the current price action represents an orchestrated shakeout or a fundamental repricing of the data center infrastructure trade, sentiment remains polarized between those viewing the decline as a major buying opportunity and those concerned about the impact of high-beta market conditions.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is trending following a record-breaking earnings beat and raised full-year guidance that solidified its role in powering AI data centers. Investors are actively debating the stock's future, weighing institutional conviction and strong operational momentum against broader market volatility.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is seeing massive volatility as traders react to a broader memory and semiconductor sector reversal, fueled by positive earnings read-throughs from Microsoft and hopes that the recent SK Hynix-led washout is finally behind the market. Community discussion remains polarized, with many retail traders hunting for a bottom while others warn that the stock remains extended and prone to further pressure.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following the UAE's approval of Anktiva for both BCG-unresponsive bladder cancer and metastatic non-small cell lung cancer, marking a significant expansion of its global footprint. While community sentiment remains polarized between optimistic bulls focusing on this regulatory momentum and bearish traders highlighting the stock's recent volatility and ongoing short interest, investors are now shifting their attention to the upcoming quarterly earnings for confirmation of commercial sales growth.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending due to heightened community discussion surrounding an upcoming maintenance dosing data readout and anticipation for its Q2 earnings call. Investors are focused on the company's clinical pipeline progress, with many debating the implications of a recent board appointment and ongoing volatility driven by speculation regarding potential M&A activity.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana is trending due to the release of its latest earnings report, which triggered sharp volatility as investors weighed a record-breaking quarter against full-year guidance that failed to meet lofty market expectations. The community remains deeply polarized, with active debates pitting bulls who point to sustained growth and operational execution against bears who continue to allege accounting irregularities and express skepticism regarding the company's subprime lending model.

Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.

Phathom Pharmaceuticals Inc

Phathom Pharmaceuticals is gaining momentum as investors focus on its path to operating profitability by the third quarter of 2026 and robust year-over-year revenue growth. The community is actively discussing the potential for a short squeeze given the high short interest, while also monitoring management's commercial strategy and the ongoing adoption of Voquezna as a standard-of-care gastrointestinal treatment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

OCUL Stock Is Climbing Ahead Of Investor Day — What Is On The Agenda?

Equity

Ocular said its U.S. Food and Drug Administration-aligned New Drug Application for wet age-related macular degeneration therapy is expected to be submitted in the fourth quarter of 2026.

Ocular Therapeutix vs. Prime Medicine: Which Healthcare Stock Is a Better Buy in 2026?

Key PointsOcular Therapeutix is transitioning into a major player in the retinal disease market with its lead program, Axpaxli...

Acuta Capital Sells 56% of Ocular Therapeutix Shares in Q1

Key PointsAcuta Capital Partners reduced its Ocular Therapeutix holding by 460,887 shares...

What This Fund's $14 Million Ocular Therapeutix Exit Could Signal for Investors

Key PointsSaturn V sold 1,504,880 shares of Ocular Therapeutix in the first quarter; the estimated transaction value was $14.34 million...

Dole Posts Downbeat Q1 Earnings, Joins Ocular Therapeutix And Other Big Stocks Moving Lower In Monday's Pre-Market Session

U.S. stock futures down 0.1%, Dole PLC drops 5.9% after missing earning estimates, other stocks also decline in pre-market trading.read more...

Ocular Therapeutix (NASDAQ:OCUL) Receives "Outperform" Rating from Royal Bank Of Canada

Royal Bank Of Canada reaffirmed an "outperform" rating and issued a $30.00 target price on shares of Ocular Therapeutix in a report on Wednesday...

Ocular Therapeutix Q1 Earnings Call Highlights

Ocular Therapeutix (NASDAQ:OCUL) management used its first-quarter 2026 earnings call to highlight clinical and regulatory progress for AXPAXLI, the company's investigational therapy for wet...

Ocular Therapeutix (NASDAQ:OCUL) Releases Quarterly Earnings Results, Misses Estimates By $0.08 EPS

Ocular Therapeutix (NASDAQ:OCUL - Get Free Report) announced its earnings results on Tuesday. The biopharmaceutical company reported ($0.40) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.32) by ($0.08). The firm had revenue of $10.79 million for the quarter...

Ocular Therapeutix (OCUL) Reports Q1 Loss, Misses Revenue Estimates

Ocular Therapeutix (OCUL) delivered earnings and revenue surprises of -29.46% and -15.29%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Ocular Therapeutix (NASDAQ:OCUL) Share Price Crosses Above 50 Day Moving Average   - Here's What Happened

Ocular Therapeutix (NASDAQ:OCUL) Stock Price Crosses Above Fifty Day Moving Average - Here's What Happened...

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

OCULOcular Therapeutix Inc

Fundamentals

Latest OCUL News